1.1.1.188 prostaglandin-F synthase vascular smooth muscle cell - 725083 1.1.1.21 aldose reductase vascular smooth muscle cell - 697639, 711859 1.10.5.1 ribosyldihydronicotinamide dehydrogenase (quinone) vascular smooth muscle cell suppression of vascular smooth muscle cell proliferation mediated by resveratrol correlates with vascular smooth muscle cell downregulation 697413 1.13.11.31 arachidonate 12-lipoxygenase vascular smooth muscle cell - 727969, 742456 1.13.11.33 arachidonate 15-lipoxygenase vascular smooth muscle cell - -, 742845 1.14.14.18 heme oxygenase (biliverdin-producing) vascular smooth muscle cell - 686599 1.14.15.18 calcidiol 1-monooxygenase vascular smooth muscle cell - 658460 1.14.99.66 [histone H3]-N6,N6-dimethyl-L-lysine4 FAD-dependent demethylase vascular smooth muscle cell - 697355 1.17.3.2 xanthine oxidase vascular smooth muscle cell - 744635 1.3.1.72 DELTA24-sterol reductase vascular smooth muscle cell - 763004 1.4.3.13 protein-lysine 6-oxidase vascular smooth muscle cell - 685981, 686904, 687919, 695968, 699875 1.4.3.21 primary-amine oxidase vascular smooth muscle cell - 701561 1.6.2.2 cytochrome-b5 reductase vascular smooth muscle cell - 742308 1.6.3.1 NAD(P)H oxidase (H2O2-forming) vascular smooth muscle cell - 724778 1.6.3.1 NAD(P)H oxidase (H2O2-forming) vascular smooth muscle cell primary cells. Glucose-mediated decreases in protein kinase G-I levels are inhibited by superoxide scavenger tempol or NAD(P)H oxidase inhibitors diphenylene iodonium or apocynin. High glucose exposure time-dependently increases superoxide production, which is abolished by tempol or apocynin treatment, but not by L-NAME, rotenone, or oxypurinol.Total protein levels and phosphorylated levels of subunit p47phox are increased after high glucose exposure. Transfection of cells with siRNA-p47phox abolishes glucose-induced superoxide production and restores protein kinase G-I protein levels 686862 1.6.5.10 NADPH dehydrogenase (quinone) vascular smooth muscle cell - 699999 1.8.4.11 peptide-methionine (S)-S-oxide reductase vascular smooth muscle cell splice variant msrA2a. Multiple MSRA variants participate in the repair of oxidized proteins in vascular smooth muscle cells mitochondria 686891 2.4.1.212 hyaluronan synthase vascular smooth muscle cell - 695183, 759705 2.4.2.1 purine-nucleoside phosphorylase vascular smooth muscle cell - -, 760109 2.4.2.12 nicotinamide phosphoribosyltransferase vascular smooth muscle cell - 680749 2.7.1.107 diacylglycerol kinase (ATP) vascular smooth muscle cell - 703112 2.7.1.137 phosphatidylinositol 3-kinase vascular smooth muscle cell - 708681 2.7.1.137 phosphatidylinositol 3-kinase vascular smooth muscle cell activation of PI3K signaling is required for the inhibitory effect of Axl on mineral deposition 686112 2.7.10.1 receptor protein-tyrosine kinase vascular smooth muscle cell - 672957 2.7.10.2 non-specific protein-tyrosine kinase vascular smooth muscle cell PYK2 673110 2.7.11.12 cGMP-dependent protein kinase vascular smooth muscle cell both PKG-Ialpha and PKG-Ibeta 721982 2.7.11.12 cGMP-dependent protein kinase vascular smooth muscle cell from normal/hypertensive fetal lambs 721982 2.7.11.12 cGMP-dependent protein kinase vascular smooth muscle cell from old and young rat aorta 721982 2.7.11.12 cGMP-dependent protein kinase vascular smooth muscle cell neointimal 721982 2.7.11.12 cGMP-dependent protein kinase vascular smooth muscle cell VCSM 701630 2.7.11.12 cGMP-dependent protein kinase vascular smooth muscle cell VSMC 704619 2.7.11.15 beta-adrenergic-receptor kinase vascular smooth muscle cell - 738016 2.7.11.17 Ca2+/calmodulin-dependent protein kinase vascular smooth muscle cell i.e. VSM cell, aortic, primary, isozymes CaMKIIgammaB, CaMKIIgammaC, and CaMKIIdelta2, expression analysis, overview 671227 2.7.11.18 myosin-light-chain kinase vascular smooth muscle cell - -, 707035, 740289 2.7.11.2 [pyruvate dehydrogenase (acetyl-transferring)] kinase vascular smooth muscle cell - 739664 2.7.11.20 elongation factor 2 kinase vascular smooth muscle cell - -, 739836 2.7.11.22 cyclin-dependent kinase vascular smooth muscle cell - 708842 2.7.11.24 mitogen-activated protein kinase vascular smooth muscle cell obtained from thoracic aorta 703567 2.7.12.2 mitogen-activated protein kinase kinase vascular smooth muscle cell aortic, cell culture 663988 3.1.1.6 acetylesterase vascular smooth muscle cell kidney, cytochemistry and confocal microscopy 696095 3.1.3.16 protein-serine/threonine phosphatase vascular smooth muscle cell - 708398 3.1.3.48 protein-tyrosine-phosphatase vascular smooth muscle cell - 692217 3.1.3.5 5'-nucleotidase vascular smooth muscle cell - 681894 3.1.3.53 [myosin-light-chain] phosphatase vascular smooth muscle cell - 697357, 699755, 732145 3.1.4.1 phosphodiesterase I vascular smooth muscle cell - 713998, 750347 3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase vascular smooth muscle cell - -, 715153 3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase vascular smooth muscle cell enzyme isoform PDE1A is predominantly cytoplasmic in medial contractile vascular smoth muscle cell and nuclear in neointimal synthetic vascular smoth muscle cell 679248 3.1.4.35 3',5'-cyclic-GMP phosphodiesterase vascular smooth muscle cell - -, 711920, 715153 3.1.4.35 3',5'-cyclic-GMP phosphodiesterase vascular smooth muscle cell phosphodiesterase 5 668864 3.1.4.37 2',3'-cyclic-nucleotide 3'-phosphodiesterase vascular smooth muscle cell - 728939 3.1.4.53 3',5'-cyclic-AMP phosphodiesterase vascular smooth muscle cell - 686114 3.1.4.53 3',5'-cyclic-AMP phosphodiesterase vascular smooth muscle cell numerous PDE4D gene-derived variants including PDE4D3, PDE4D5, PDE4D7, PDE4D8, and PDE4D9 686114 3.4.19.12 ubiquitinyl hydrolase 1 vascular smooth muscle cell - 707391 3.4.19.12 ubiquitinyl hydrolase 1 vascular smooth muscle cell mRNA and protein expression, expressed in vascular smooth muscle cells in atherosclerotic lesions from human carotid arteries 677876 3.4.21.27 coagulation factor XIa vascular smooth muscle cell - 752439 3.4.21.5 thrombin vascular smooth muscle cell - 717167, 717797 3.4.21.6 coagulation factor Xa vascular smooth muscle cell - 731588 3.4.21.75 Furin vascular smooth muscle cell - 667391, 708682 3.4.21.B1 hyaluronan-binding serine protease vascular smooth muscle cell - 690121 3.4.21.B26 proprotein convertase 5 vascular smooth muscle cell - 673108, 675490 3.4.21.B26 proprotein convertase 5 vascular smooth muscle cell up-regulation of PC5 in proliferating cell nuclear antigen-positive vascular smooth muscle cells following balloon injury 675490 3.4.22.27 cathepsin S vascular smooth muscle cell - 733448 3.4.22.56 caspase-3 vascular smooth muscle cell from umbilical cord 695963 3.4.24.22 stromelysin 2 vascular smooth muscle cell - 717202 3.4.24.23 matrilysin vascular smooth muscle cell - -, 683742, 708021 3.4.24.35 gelatinase B vascular smooth muscle cell - 683111, 697149, 701317, 708188 3.4.24.7 interstitial collagenase vascular smooth muscle cell - 701317 3.5.3.1 arginase vascular smooth muscle cell - 697211 3.6.5.2 small monomeric GTPase vascular smooth muscle cell - 735277 4.1.1.17 ornithine decarboxylase vascular smooth muscle cell - 695461 4.4.1.1 cystathionine gamma-lyase vascular smooth muscle cell - 707176, 708133 4.4.1.1 cystathionine gamma-lyase vascular smooth muscle cell mainly expressed in airway and vascular smooth muscle cells in rat lung tissue 691972 4.6.1.1 adenylate cyclase vascular smooth muscle cell - 690360, 707057 4.6.1.2 guanylate cyclase vascular smooth muscle cell - 653601, 707919 5.3.4.1 protein disulfide-isomerase vascular smooth muscle cell - 727921 5.3.99.2 Prostaglandin-D synthase vascular smooth muscle cell - 660668, 682619 5.3.99.3 prostaglandin-E synthase vascular smooth muscle cell cells express both microsomal isoforms mPGES-1 and mPGES-2 and cytosolic isoform cPGES 681664 5.3.99.3 prostaglandin-E synthase vascular smooth muscle cell cells express both microsomal isoforms mPGES-1 and mPGES-2 and cytosolic isoform cPGES. Isoform mPGES-1 contributes most to total activity and is induced by interleukin IL-1beta, which in turn reduces the ability of cells to produce prostaglandin I2 681664 5.3.99.4 prostaglandin-I synthase vascular smooth muscle cell - 660924 5.3.99.5 thromboxane-A synthase vascular smooth muscle cell - 714914 5.6.1.6 channel-conductance-controlling ATPase vascular smooth muscle cell - 675622 7.2.2.10 P-type Ca2+ transporter vascular smooth muscle cell - 734295 7.2.2.8 P-type Cu+ transporter vascular smooth muscle cell - 749535, 749770 7.2.2.9 P-type Cu2+ transporter vascular smooth muscle cell - 668543 7.3.2.1 ABC-type phosphate transporter vascular smooth muscle cell expression of Pit-1 and Pit-2, Pit-1 is not a component of matrix vesicles or apoptotic bodies, expression analysis, Pit-1 is the predominant sodium-dependent phosphate cotransporter, overview 686123